ACRO Biomedical Co., Ltd. (TPEX:6748)
Taiwan · Delayed Price · Currency is TWD 61.50
-0.10 (-0.16%)
Mar 4, 2026, 9:03 AM CST
ACRO Biomedical Market Cap
ACRO Biomedical has a market cap or net worth of 3.77 billion as of March 3, 2026. Its market cap has increased by 167.24% in one year.
Market Cap
3.77B
Enterprise Value
3.33B
Revenue
36.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
61.50
Market Cap Chart
Since July 27, 2021, ACRO Biomedical's market cap has increased from 990.62M to 3.77B, an increase of 280.68%. That is a compound annual growth rate of 33.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 3.77B | -6.67% |
| Dec 31, 2025 | 4.04B | 158.32% |
| Dec 31, 2024 | 1.56B | -35.07% |
| Dec 29, 2023 | 2.41B | 135.16% |
| Dec 30, 2022 | 1.02B | 9.09% |
| Dec 30, 2021 | 938.97M | -5.21% |
| Jul 27, 2021 | 990.62M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senhwa Biosciences | 4.51B |
| Energenesis Biomedical CO.,LTD. | 4.49B |
| Medigen Biotechnology | 4.21B |
| Formosa Pharmaceuticals | 4.20B |
| Intech Biopharm | 4.08B |
| BRIM Biotechnology | 3.62B |
| Genovate Biotechnology | 3.62B |
| Sagittarius Life Science | 3.48B |